Yael Hirsch-Moverman

Yael Hirsch-Moverman

Yael Hirsch-Moverman

Assistant Professor
Epidemiology (In ICAP) at the Columbia University Medical Center

Office/Address:

Harlem Prevention Center; 215 W. 125th Street, 1st floor, Suite A
New York NY USA 10027
Phone:
646-524-8344
Website address: Email:

Biography

Yael Hirsch-Moverman is an epidemiologist with over 20 years of experience in epidemiologic and operations research, specifically experience in designing, conducting, and analyzing interventions to improve patient care and retention in TB and HIV programs in resource-limited settings such as Lesotho and Ethiopia. She supports and leads a number of implementation science research studies to prevent TB in resource-limited settings. She also supports multiple studies that aim to prevent HIV in key populations in the US.

Education

BA, 1990, Queens College
MS, 1991, Columbia University's School of Engineering and Applied Science
MPH, 2001, Columbia University's Mailman School of Public Health
PhD, 2011, Columbia University's Mailman School of Public Health

Mailman Affiliations

Assistant Professor in Epidemiology, Department of Epidemiology
Technical Advisor, Clinical and Training Unit, ICAP

Select Publications

Hirsch-Moverman Y, Howard AA, Frederix K, Lebelo L, Hesseling A, Nachman S, Mantell JE, Lekhela T, Maama LB, El-Sadr WM. The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trial. Trials. 2017;18(1):552. doi: 10.1186/s13063-017-2184-0. PubMed PMID: 29157275; PubMed Central PMCID:PMC5697438.
Szkwarko D, Hirsch-Moverman Y, Du Plessis L, Du Preez K, Carr C, Mandalakas AM. Child contact management in high tuberculosis burden countries: A mixed-methods systematic review. PLoS One. 2017;12(8):e0182185. doi: 10.1371/journal.pone.0182185. PubMed PMID: 28763500; PubMed Central PMCID:PMC5538653
Hirsch-Moverman Y, Burkot C, Saito S, Frederix K, Pitt B, Melaku Z, Gadisa T, Howard AA. Reaching the end of the line: Operational issues with implementing phone-based unannounced pill counts in resource-limited settings. PLoS One. 2017;12(10):e0185549. doi: 10.1371/journal.pone.0185549. PubMed PMID: 29049382; PubMed Central PMCID:PMC5648117
Howard AA, Hirsch-Moverman Y, Saito S, Gadisa T, Daftary A, Melaku Z. The ENRICH study to evaluate the effectiveness of a combination intervention package to improve isoniazid preventive therapy initiation, adherence and completion among people living with HIV in Ethiopia: Rationale and design of a mixed methods cluster randomized trial. Contemporary Clinical Trials Communications. 6 (2017) 46e54
Hirsch-Moverman Y, Daftary A, Yuengling KA, Saito S, Ntoane, M. Frederix K, Maama LB, and Howard AA. Using mHealth for HIV/TB Treatment Support in Lesotho: Enhancing Patient–Provider Communication in the START Study. J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1:S37-S43
Daftary, A, Hirsch-Moverman, Y, Kassie, GM, Melaku, Z, Gadisa, T, Saito, S, Howard, AA. A qualitative evaluation of the acceptability of an interactive voice response system to enhance adherence to isoniazid preventive therapy among people living with HIV in Ethiopia. AIDS Behav. 2016. doi:10.1007/s10461-016-1432-8
Grant RM, Mannheimer S, Hughes JP, Hirsch-Moverman Y, Loquere A, Chitwarakorn A, Curlin ME, Li M, Amico KR, Hendrix CW, Anderson PL, Dye BJ, Marzinke MA, Piwowar-Manning E, McKinstry L, Elharrar V, Stirratt M, Rooney JF, Eshleman SH, McNicholl JM, van Griensven F, Holtz TH. Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex With Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study. Clin Infect Dis. 2018. doi: 10.1093/cid/cix1086. PubMed PMID: 29420695.
Franks J, Mannheimer SB, Hirsch-Moverman Y, Hayes-Larson E, Colson PW, Ortega H, El-Sadr WM. Multiple strategies to identify HIV-positive black men who have sex with men and transgender women in New York City: a cross-sectional analysis of recruitment results. J Int AIDS Soc. 2018;21(3). Epub 2018/03/15. doi: 10.1002/jia2.25091. PubMed PMID: 29537178; PubMed Central PMCID:PMC5850046
Howard AA, Hirsch-Moverman Y, Frederix K, Daftary A, Saito S, Gross T, Wu Y, and Maama LB. The START Study to evaluate the effectiveness of a combination intervention package to enhance antiretroviral therapy uptake and retention during TB treatment among TB/HIV patients in Lesotho: rationale and design of a mixed-methods, cluster-randomized trial. Glob Health Action. 2016, 9: 31543 - http://dx.doi.org/10.3402/gha.v9.31543
Hayes-Larson E, Hirsch-Moverman Y, Saito S, Frederix K, Pitt B, Maama-Maime L, Howard AA. Depressive symptoms and hazardous/harmful alcohol use are prevalent and correlate with stigma among TB-HIV patients in Lesotho. Int J Tuberc Lung Dis. 2017;21(11):34-41. doi: 10.5588/ijtld.17.0062. PubMed PMID: 29025483; PubMed Central PMCID:PMC5776389

Back to Top